MAHA vs. Mainstream: The CDC Vaccine Fault Line

Robert F. Kennedy Jr. suspends his independent presidential campaign and endorses Donald Trump, signaling a deal for influence over U.S. health policy.

Donald Trump wins the presidential election. RFK Jr.'s MAHA movement is credited as a key coalition partner in swing-state margins.

President-elect Trump nominates Robert F. Kennedy Jr. as Secretary of Health and Human Services, fulfilling a key coalition promise.

CDC Director Mandy Cohen, appointed under Biden, leaves office at the start of the Trump administration. The directorship enters an extended vacancy.

Senate confirms RFK Jr. as HHS Secretary 52–48 along party lines. He immediately signals plans to restructure federal health agencies.

HHS cancels a scheduled meeting of the Advisory Committee on Immunization Practices (ACIP), the independent body that recommends vaccine schedules.

A second consecutive ACIP meeting is cancelled with no rescheduling announced, raising alarms among pediatricians and public health officials.

RFK Jr. announces sweeping HHS reorganization, cutting staff and consolidating agencies. CDC workforce reduced by approximately 2,400 positions.

HHS cancels a third ACIP meeting. Vaccine manufacturers warn of uncertainty in the immunization schedule pipeline.

Trump nominates Dr. Susan Monarez, a biodefense and infectious disease specialist, as CDC Director. Her conventional vaccine stance immediately draws MAHA backlash.

Prominent MAHA activists and aligned media figures publicly oppose the CDC nominee, calling her a 'pharma-aligned pick' incompatible with the movement's goals.